Title: A non-interventional, prospective 12 months study to characterize the REAL-life effectiveness and treatment patterns of Secukinumab and current standard of care in patient with chronic plaque psoriAsis eligible for systemic treatment in the Asia Pacific and Middle East regions (REALIA)
Aim: Evaluate patterns of care and real world effectiveness of secukinumab, other biologics and systemic therapies in management of chronic plaque psoriasis eligible to systemic treatment
